Intensive Outpatient Treatment for Alcohol and Other Drug Abuse: A Treatment Improvement Protocol
Anna Marsh, Sandra Clunies
DIANE Publishing, 1994 - Psychology - 104 pages
Prepared to facilitate the transfer of state-of-the-art protocols and guidelines for the treatment of alcohol and other drug (AOD) abuse from acknowledged clinical, research, and administrative experts to the Nation's AOD abuse treatment resources. Includes: placement criteria and expected treatment outcomes; components of an effective IOT (intensive outpatient treatment) program; staffing issues and guidelines; the treatment needs of special groups; special fiscal and administrative issues; and legal issues for IOT programs. Extensive references. Sample IOT program schedules.
What people are saying - Write a review
We haven't found any reviews in the usual places.
activities Addiction Medicine administrative Alcoholics Anonymous AOD abuse treatment AOD disorders AOD problems AOD treatment programs AOD use disorders appropriate assessment behavioral Center child abuse clients clinical clinical supervision clinicians consent form counseling counselor criminal justice system cultural Director disclosed disclosure Drug Abuse dual disorders duty to warn effective employer enhance ensure evaluation example family members family therapy group therapy guidelines homeless identify individual inpatient treatment intensive outpatient treatment interventions involvement IOT level IOT programs IOT setting IOT staff issues lesbian linkages managed care Medicaid medical management meetings mental health monitoring ongoing organized outcome patient placement payers placement criteria potential professionals psychiatric Rational Recovery reimbursement relationships require responsibility scheduled screening sessions skills social special groups specific staff members Substance Abuse therapeutic treatment and recovery treatment goals Treatment Improvement Protocol treatment needs treatment plan treatment providers women
Page ii - A maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by one (or more) of the following, occurring within a 12-month period: 1) recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (eg, repeated absences or poor work performance related to substance use; substance-related absences, suspensions...
Page ii - ... important social, occupational, or recreational activities are given up or reduced because of substance use 7. the substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance...
Page 82 - The specific name or general designation of the program or person permitted to make the disclosure. (2) The name or title of the individual or the name of the organization to which disclosure is to be made. (3) The name of the patient. (4) The purpose of the disclosure. (5) How much and what kind of information is to be disclosed. (6) The signature of the patient and, when required for a patient who...
Page 85 - Thus it may call for him to warn the intended victim or others likely to apprise the victim of the danger, to notify the police, or to take whatever other steps are reasonably necessary under the circumstances.
Page ii - There is a persistent desire or unsuccessful efforts to cut down or control substance use. 5. A great deal of time is spent in activities necessary to obtain the substance...
Page 90 - Under the procedures required by paragraph (c) of this section, patient identifying information may be disclosed to medical personnel who have a need for information about a patient for the purpose of treating a condition which poses an immediate threat to the health of any individual and which requires immediate medical intervention.
Page 81 - Part 2). The Federal rules prohibit you from making any further disclosure of this information unless further disclosure is expressly permitted by the written consent of the person to whom it pertains or as otherwise permitted by 42 CFR Part 2.
Page ii - A. Maladaptive pattern of substance use, leading to clinically significant impairment or distress, as manifested by three (or more) of the following, occurring at any time in the same 12-month period: (1) Tolerance, as defined by either of the following: (a) A need for markedly increased amounts of the substance to achieve intoxication or desired effect. or (b) Markedly diminished effect with continued use of the same amount of the substance.
Page 92 - Confidentiality of Alcohol and Drug Abuse Patient Records, 42 CFR Part 2, and cannot be disclosed without my written consent unless otherwise provided for in the regulations.